GGrantIndex
← Search

A single mutation-independent AAV gene therapy for the treatment of autosomal-dominant retinitis pigmentosa.

$882,971R44FY2024EYNIH

Opus Genetics Inc., Raleigh NC

Investigators

Benjamin R Yerxacontact
View original record on NIH RePORTER →
A single mutation-independent AAV gene therapy for the treatment of autosomal-dominant retinitis pigmentosa. · GrantIndex